Global Juvenile Macular Degeneration Clinical Trials Review 2024, Featuring Lin Bioscience, Nanoscope Therapeutics, Alnylam Pharmaceuticals, Biophytis, Kubota Pharmaceutical and Nucleus Network
27 mai 2024 05h00 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Global Uveitis Treatment Research Report 2024: Market to Reach $1.34 Billion by 2034, Fueled by Increased Prevalence, Treatment Improvements, and Strategic Alliances & Collaborations
16 mai 2024 10h30 HE
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Global Uveitis Treatment Market" report has been added to ResearchAndMarkets.com's offering.The global uveitis treatment market accounted for USD 753...
Uveitis Treatment Market and Competitive Landscape Report, 2024: Analysis of Growth Opportunities by Drug Class, Disease Type, Distribution Channel, and Region to 2030
16 mai 2024 07h11 HE
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Uveitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...
Global Neurotrophic Keratitis Market Report 2024, with Profiles of Dompe, Oyster Point Pharma, Neuroptica, Recordati Rare Diseases, KALA BIO, ReGenTree, BRIM Biotechnology, Oculis and HLB Therapeutics
14 mai 2024 08h57 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global Neurotrophic Keratitis Market Outlook 2023-2036" report has been added to ResearchAndMarkets.com's offering.The global neurotrophic keratitis...
Global $20B+ Macular Degeneration Treatment Market Outlook, 2024-2029: AI Integration Paves the Way for Personalized Care
10 mai 2024 05h15 HE
|
Research and Markets
Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Global $15.4 Billion Macular Degeneration Treatment Market, 2032: Modern Dietary Routines and Sedentary Lifestyles Driving the Incidence of Macular Degeneration
07 mai 2024 12h39 HE
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Global Macular Degeneration Treatment Market Report by Type, Stage of Disease, Route of Administration, End User, and Region 2024-2032" report has been...
Batoclimab (IMVT-1401) for Graves' Ophthalmopathy Drug Landscape Report 2024: Market Size, Forecast, and Emerging Insights for 7MM 2019-2032
29 avr. 2024 10h39 HE
|
Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Batoclimab Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Ophthalmics Collaboration and Licensing Deals Collection, 2019-2024: Leading Deals by Value, Most Active Dealmakers, Benchmark Analysis, Financial Terms, and More
25 avr. 2024 10h33 HE
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Ophthalmics Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Ophthalmics Collaboration and...
Comprehensive Insights on Progressive Keratoconus Drug Pipeline for 2024: Detailed Assessment of Commercial and Clinical Progression
23 avr. 2024 07h55 HE
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Progressive Keratoconus - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. This report presents a rigorous...
Leber Congenital Amaurosis Pipeline Insight 2024, Featuring Key Players ProQR Therapeutics, Editas Medicine, Atsena Therapeutics, Applied Genetic Technologies, IVERIC bio and MeiraGTx
22 avr. 2024 07h51 HE
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Leber congenital amaurosis - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides...